TRNM: A Protein Targeted By Drugs for A Variety of Diseases (G4569)

Target Name: TRNM

NCBI ID: G4569

TRNM

Other Name(s): MT-TM | tRNA-Met | mitochondrially encoded tRNA methionine | MTTM | mitochondrially encoded tRNA-Met (AUA/G)

TRNM: A Protein Targeted By Drugs for A Variety of Diseases

TRNM (Tissue Response to Medication) is a drug target (also known as a biomarker) that is a molecule that is targeted by a drug in order to interact with it and cause a specific response in the body. TRNM is a protein that is expressed in various tissues throughout the body, including the brain, heart, liver, and kidneys. It is involved in many different processes in the body, including cell signaling, inflammation, and immune response.

One of the key benefits of identifying TRNM as a drug target is that it allows researchers to develop new treatments for a wide range of diseases. By blocking the action of TRNM, drugs can interrupt the signaling pathways that are involved in many different diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. This can lead to a more effective and targeted treatment approach.

Another advantage of TRNM as a drug target is that it provides researchers with a useful tool for studying the underlying mechanisms of many different diseases. By studying how TRNM interacts with other molecules in the body, researchers can gain insights into the factors that contribute to the development and progression of these diseases. This can help to identify new potential targets for treatment and to develop new therapies that are more effective and safer.

In addition to its potential as a drug target, TRNM is also a potential biomarker for many different diseases. By measuring the levels of TRNM in body tissues, researchers can monitor the effectiveness of a drug and determine whether it is having the desired effect. This can be a valuable tool for evaluating the effectiveness of new treatments and for monitoring the course of a disease.

Overall, TRNM is a protein that is involved in many different processes in the body, and it has the potential to be a drug target and a biomarker for many different diseases. Further research is needed to fully understand the role of TRNM in the body and to develop new treatments based on this protein.

Protein Name: Mitochondrially Encoded TRNA Methionine

The "TRNM Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TRNM comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets